Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSKIN: Sirolimus for Skin Cancer Prevention in Renal Transplant
NCT01797315Phase 4Terminated
- Start
- Mar 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of sirolimus in skin cancer, actinic keratosis (AK), squamous cell carcinoma (SCC), basal cell carcinoma (BCC). Started Mar 2007; status: terminated.
02
Drugs
sirolimus
03
Conditions
skin canceractinic keratosis (AK)squamous cell carcinoma (SCC)basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01797315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797315.